Ranogelan

Medicinal product

(Invented) name

Ranogelan

Active substance (s)

Ranolazinas

Strength

375 mg

Pharmaceutical form

pailginto atpalaidavimo tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C01EB18, Ranolazine

Marketing authorisation holder

G.L. Pharma GmbH, Austrija

Date of authorisation

2022-07-08

Date of renewal

Documents

4981_4982_4983 Pakuotės lapelis 2023 01 26.docx

4981_4982_4983 Ranogelan II PL 2023 01 26.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

NL/H/5344/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Ranolazinas	375 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
108959	95065	1095065	lizdinė plokštelė	N30		Receptinis	LT/1/22/4981/001	Netiekiama	-	-	No	-	-
108960	95066	1095066	lizdinė plokštelė	N60		Receptinis	LT/1/22/4981/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2022-07-08	Registruotas